Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Departments of Medical Biophysics and Biochemistry, University of Toronto, Toronto, Ontario, Canada.
J Biol Chem. 2020 Oct 16;295(42):14458-14472. doi: 10.1074/jbc.REV120.013731. Epub 2020 Aug 12.
Fungi inhabit extraordinarily diverse ecological niches, including the human body. Invasive fungal infections have a devastating impact on human health worldwide, killing ∼1.5 million individuals annually. The majority of these deaths are attributable to species of , and Treating fungal infections is challenging, in part due to the emergence of resistance to our limited arsenal of antifungal agents, necessitating the development of novel therapeutic options. Whereas conventional antifungal strategies target proteins or cellular components essential for fungal growth, an attractive alternative strategy involves targeting proteins that regulate fungal virulence or antifungal drug resistance, such as regulators of fungal stress responses. Stress response networks enable fungi to adapt, grow, and cause disease in humans and include regulators that are highly conserved across eukaryotes as well as those that are fungal-specific. This review highlights recent developments in elucidating crystal structures of fungal stress response regulators and emphasizes how this knowledge can guide the design of fungal-selective inhibitors. We focus on the progress that has been made with highly conserved regulators, including the molecular chaperone Hsp90, the protein phosphatase calcineurin, and the small GTPase Ras1, as well as with divergent stress response regulators, including the cell wall kinase Yck2 and trehalose synthases. Exploring structures of these important fungal stress regulators will accelerate the design of selective antifungals that can be deployed to combat life-threatening fungal diseases.
真菌栖息在极其多样的生态位,包括人体。侵袭性真菌感染对全球人类健康造成严重影响,每年导致约 150 万人死亡。这些死亡大多归因于 、 和 。治疗真菌感染具有挑战性,部分原因是对我们有限的抗真菌药物产生了耐药性,需要开发新的治疗选择。虽然传统的抗真菌策略针对的是真菌生长所必需的蛋白质或细胞成分,但一种有吸引力的替代策略是针对调节真菌毒力或抗真菌药物耐药性的蛋白质,例如调节真菌应激反应的蛋白质。应激反应网络使真菌能够适应、生长并在人类中引起疾病,其中包括在真核生物中高度保守的调节剂以及真菌特异性调节剂。这篇综述强调了阐明真菌应激反应调节剂晶体结构的最新进展,并强调了这方面的知识如何指导真菌选择性抑制剂的设计。我们专注于高度保守的调节剂的进展,包括分子伴侣 Hsp90、蛋白磷酸酶钙调神经磷酸酶和小 GTP 酶 Ras1,以及不同的应激反应调节剂,包括细胞壁激酶 Yck2 和海藻糖合酶。探索这些重要的真菌应激调节剂的结构将加速设计选择性抗真菌药物,以对抗危及生命的真菌感染。